Adicet Bio, Inc.

NASDAQ:ACET

0.76 (USD) • At close September 8, 2025
Bedrijfsnaam Adicet Bio, Inc.
Symbool ACET
Munteenheid USD
Prijs 0.763
Beurswaarde 63,505,999
Dividendpercentage 0%
52-weken bereik 0.447 - 1.63
Industrie Biotechnology
Sector Healthcare
CEO Mr. Chen Schor BA, CPA, CPA, M.B.A., MBA
Website https://www.adicetbio.com

An error occurred while fetching data.

Over Adicet Bio, Inc.

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and

Vergelijkbare Aandelen

Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc.

PRAX

40.75 USD

Vaxart, Inc. logo

Vaxart, Inc.

VXRT

0.385 USD

Kinnate Biopharma Inc. logo

Kinnate Biopharma Inc.

KNTE

2.65 USD

Rallybio Corporation logo

Rallybio Corporation

RLYB

0.594 USD

Day One Biopharmaceuticals, Inc. logo

Day One Biopharmaceuticals, Inc.

DAWN

7.47 USD

Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd.

DRTS

3.69 USD

IRadimed Corporation logo

IRadimed Corporation

IRMD

71.85 USD

RAPT Therapeutics, Inc. logo

RAPT Therapeutics, Inc.

RAPT

13.28 USD

Nuvalent, Inc. logo

Nuvalent, Inc.

NUVL

79.83 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)